Dodge & Cox decreased its stake in News Corp (NWSA) by 1.99% based on its latest 2018Q1 regulatory filing with the SEC. Dodge & Cox sold 237,375 shares as the company’s stock declined 6.37% with the market. The institutional investor held 11.69M shares of the newspapers and magazines company at the end of 2018Q1, valued at $184.64M, down from 11.92 million at the end of the previous reported quarter. Dodge & Cox who had been investing in News Corp for a number of months, seems to be less bullish one the $9.41 billion market cap company. The stock increased 0.56% or $0.09 during the last trading session, reaching $16.04. About 23,913 shares traded. News Corporation (NASDAQ:NWSA) has risen 17.94% since June 20, 2017 and is uptrending. It has outperformed by 5.37% the S&P500. Some Historical NWSA News: 10/05/2018 – News Corp 3rd-Quarter News and Information Services Revenue $1.29 Billion; 18/04/2018 – NAR, realtor.com® Report Housing Supply and Affordability Are at Odds in Markets Across U.S; 13/03/2018 – NEWS CORP SAYS BALLBALL TO BECOME PART OF NEW ENTITY – DUGOUT SE ASIA; 18/04/2018 – Dow Jones Media Group Partners With Brave Software To Offer Premium Content To Users and Test Blockchain-Based Payment; 19/03/2018 – DOW JONES – DOW JONES RISK & COMPLIANCE COMPLETED ACQUISITION OF CERICO FROM LAW FIRM PINSENT MASONS AND CAMPBELL NASH; 05/03/2018 – News Corp, Telstra Agree to Combine Foxtel and Foxtel Sports Australia; 04/04/2018 – Millennial Buyers Feel the Brunt of Rate and Price Hikes; 30/03/2018 – Rising Rents Push Millennials to Become Homeowners; 09/05/2018 – 21ST CENTURY FOX REPORTS THIRD QUARTER INCOME FROM CONTINUING OPERATIONS BEFORE INCOME TAX EXPENSE OF $1.33 BILLION AND TOTAL SEGMENT OPERATING INCOME BEFORE DEPRECIATION AND AMORTIZATION OF $1.8…; 05/03/2018 – News Corp Expects to Record $700M to $1.1B Impairment Charges, Write-downs in Quarter Ending March 31
Blue Edge Capital Llc decreased its stake in Abbvie Inc (ABBV) by 9.6% based on its latest 2018Q1 regulatory filing with the SEC. Blue Edge Capital Llc sold 299 shares as the company’s stock declined 16.83% with the market. The institutional investor held 2,814 shares of the major pharmaceuticals company at the end of 2018Q1, valued at $266.37M, down from 3,113 at the end of the previous reported quarter. Blue Edge Capital Llc who had been investing in Abbvie Inc for a number of months, seems to be less bullish one the $148.86 billion market cap company. The stock increased 0.32% or $0.31 during the last trading session, reaching $98.32. About 251,828 shares traded. AbbVie Inc. (NYSE:ABBV) has risen 52.41% since June 20, 2017 and is uptrending. It has outperformed by 39.84% the S&P500. Some Historical ABBV News: 01/05/2018 – ABBVIE SUBMITS MARKETING AUTHORIZATION APPLICATION TO EMA FOR; 13/03/2018 – FDA PRIORITY REVIEW OF KEYTRUDA IN ADVANCED CERVICAL CANCER; 05/04/2018 – BIOGEN: PRECISE TERMS OF PACT WITH ABBVIE ARE CONFIDENTIAL; 22/04/2018 – DJ AbbVie Inc, Inst Holders, 1Q 2018 (ABBV); 08/05/2018 – J&J’s Janssen: FDA Approval Marks the Fifth Indication for Darzalex, Which Is the First CD38-Directed Antibody to Be Approved Anywhere; 13/03/2018 – X-Chem Announces Licensing of Two Discovery Programs to AbbVie; 16/04/2018 – Biothera Pharmaceuticals Presents Translational Data from Ongoing Clinical Trials Showing lmprime PGG in Combination with Merck’s KEYTRUDA® (pembrolizumab) Drives lnnate and Adaptive Immune Responses in Tumors; 21/03/2018 – AbbVie and the International Myeloma Foundation Announce Partnership to Study the Role of a Genetic Mutation in Outcomes of Pat; 30/04/2018 – Merck Seeks Approval for Keytruda Combo as First-Line Treatment for Metastatic Nonsquamous NSCLC; 23/04/2018 – EUROPEAN MEDICINES AGENCY VALIDATES TYPE Il VARIATION FOR MERCK’S KEYTRUDA® (PEMBROLIZUMAB) IN COMBINATION WITH PEMETREXED (ALIMTA®) AND PLATINUM CHEMOTHERAPY AS FIRST-LINE THERAPY IN METASTATIC…
Since February 19, 2018, it had 0 insider purchases, and 9 sales for $25.06 million activity. Shares for $119,351 were sold by Michael Robert A.. Schumacher Laura J sold $2.95 million worth of stock. RICHMOND TIMOTHY J. also sold $2.15M worth of AbbVie Inc. (NYSE:ABBV) on Wednesday, February 28. Another trade for 83,574 shares valued at $9.57M was made by ALBAN CARLOS on Wednesday, February 28. GONZALEZ RICHARD A had sold 8,280 shares worth $976,084 on Wednesday, February 28. CHASE WILLIAM J also sold $8.31 million worth of AbbVie Inc. (NYSE:ABBV) on Wednesday, February 28.
More notable recent AbbVie Inc. (NYSE:ABBV) news were published by: Fool.com which released: “Forget Johnson & Johnson: Here Are 2 Better Dividend Stocks” on June 20, 2018, also Seekingalpha.com with their article: “AbbVie: Growth And Dividend In One Package” published on June 15, 2018, Seekingalpha.com published: “More Thoughts On AbbVie’s Rova-T Implosion” on June 06, 2018. More interesting news about AbbVie Inc. (NYSE:ABBV) were released by: Seekingalpha.com and their article: “Translate Bio readies IPO” published on June 02, 2018 as well as Seekingalpha.com‘s news article titled: “Premarket analyst action – healthcare” with publication date: June 01, 2018.
Among 24 analysts covering Abbvie Inc (NYSE:ABBV), 9 have Buy rating, 3 Sell and 12 Hold. Therefore 38% are positive. Abbvie Inc had 96 analyst reports since July 21, 2015 according to SRatingsIntel. On Tuesday, January 30 the stock rating was downgraded by BMO Capital Markets to “Underperform”. The company was maintained on Friday, April 27 by Credit Suisse. The rating was maintained by Argus Research with “Buy” on Monday, June 11. The firm has “Hold” rating given on Monday, January 29 by Credit Suisse. BMO Capital Markets downgraded the shares of ABBV in report on Friday, June 10 to “Market Perform” rating. On Friday, February 5 the stock rating was initiated by William Blair with “Outperform”. As per Wednesday, June 7, the company rating was maintained by BMO Capital Markets. Morgan Stanley downgraded the stock to “Equal-Weight” rating in Wednesday, June 8 report. The firm earned “Buy” rating on Monday, July 17 by Jefferies. As per Friday, July 28, the company rating was maintained by Cowen & Co.
Blue Edge Capital Llc, which manages about $153.03M and $248.22 billion US Long portfolio, upped its stake in Ishares Barclays Mbs Bond (MBB) by 2,187 shares to 37,126 shares, valued at $3.88B in 2018Q1, according to the filing. It also increased its holding in Mkt Vctrs J P Mrgn Em by 9,163 shares in the quarter, for a total of 158,023 shares, and has risen its stake in Spdr Blmbrg Brcly Sht (SJNK).
Analysts await AbbVie Inc. (NYSE:ABBV) to report earnings on July, 27. They expect $1.97 EPS, up 38.73% or $0.55 from last year’s $1.42 per share. ABBV’s profit will be $2.98 billion for 12.48 P/E if the $1.97 EPS becomes a reality. After $1.87 actual EPS reported by AbbVie Inc. for the previous quarter, Wall Street now forecasts 5.35% EPS growth.
Investors sentiment decreased to 0.7 in 2018 Q1. Its down 0.10, from 0.8 in 2017Q4. It dropped, as 61 investors sold ABBV shares while 737 reduced holdings. 127 funds opened positions while 428 raised stakes. 1.06 billion shares or 0.67% less from 1.06 billion shares in 2017Q4 were reported. Boyd Watterson Asset Ltd Liability Company Oh has 1.88% invested in AbbVie Inc. (NYSE:ABBV) for 39,990 shares. Wheatland Advisors invested 0.59% of its portfolio in AbbVie Inc. (NYSE:ABBV). Chemung Canal Com stated it has 0.37% in AbbVie Inc. (NYSE:ABBV). Miller Howard Invs New York has 1.56% invested in AbbVie Inc. (NYSE:ABBV) for 698,697 shares. Sfmg Limited Liability has invested 0.08% in AbbVie Inc. (NYSE:ABBV). Calamos Advsr Ltd Liability invested in 1.13M shares or 0.69% of the stock. Edge Wealth Management Limited Liability holds 1,000 shares or 0.03% of its portfolio. Fincl Advisory owns 3,700 shares for 0.11% of their portfolio. Denver Advsrs Ltd Llc holds 95,360 shares. 46,816 are held by Wellington Management Group Ltd Liability Partnership. Front Barnett Associate Ltd Liability has 0.13% invested in AbbVie Inc. (NYSE:ABBV) for 8,198 shares. Northwest Counselors Ltd Company, a Oregon-based fund reported 8,121 shares. Arrowstreet Cap Limited Partnership reported 1.78% of its portfolio in AbbVie Inc. (NYSE:ABBV). Amarillo National Bank & Trust has invested 0.14% of its portfolio in AbbVie Inc. (NYSE:ABBV). Butensky And Cohen Fin Security has 1.45% invested in AbbVie Inc. (NYSE:ABBV).
Dodge & Cox, which manages about $123.87 billion US Long portfolio, upped its stake in Johnson Controls International by 19.39 million shares to 95.36 million shares, valued at $3.36B in 2018Q1, according to the filing. It also increased its holding in Liberty Global Plc (NASDAQ:LBTYK) by 893,700 shares in the quarter, for a total of 38.44 million shares, and has risen its stake in Wells Fargo & Co (NYSE:WFC).
Analysts await News Corporation (NASDAQ:NWSA) to report earnings on August, 9. They expect $0.07 earnings per share, down 36.36% or $0.04 from last year’s $0.11 per share. NWSA’s profit will be $41.06M for 57.29 P/E if the $0.07 EPS becomes a reality. After $0.06 actual earnings per share reported by News Corporation for the previous quarter, Wall Street now forecasts 16.67% EPS growth.